{
 "as_of": "2026-11-06",
 "cmr": "ca-cm-kg/CSE/DOSE",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Rapid Dose Therapeutics Corp. (CSE: DOSE) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nRapid Dose Therapeutics Corp. is listed on the CSE under the ticker DOSE. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. Security type is Corporate, sector is Life Sciences, and segment is not on the record. Jurisdiction is not on the record, as it was not searched. Status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 9 filings in the twelve months to 2026-11-06, across 7 filing days, all of type newswire release. The median gap between filing days is 16.5 days. Days from the latest filing to the record date are 7. The latest filing is dated 2026-10-30 and is a newswire release. CSE peers, 724 issuers, show a median cadence gap of 19.5 days, a median of 6.0 filings, and a median latency of 17.0 days. Life Sciences peers, 200 issuers, show a median cadence gap of 17.5 days, a median of 7.0 filings, and a median latency of 14 days.\n\n## Auditor\n\nThe auditor of record is SRCO Professional Corporation. Its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move events. Status is listed, not halted.\n\n## Orderability\n\nUnder the Canadian know-your-product rule (NI 31-103), both client categories, paragraph (o) and paragraph (q) of the definition, return signal ACM-200, and both outcomes are determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.\n\n## Open research\n\nThe field has not been read. The number of openly published research notes is not on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://mcp.ca-cm-kg.ai/events/CSE/DOSE (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/rapid-dose-therapeutics-corp/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/DOSE (the record)\n",
 "market": "CA",
 "node": "ca-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-10",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "CSE",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/listings/rapid-dose-therapeutics-corp/",
    "state": "sourced",
    "value": "SRCO Professional Corporation"
   },
   "auditor_firm_id": {
    "market": "CA",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "CA",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "ca-cm-kg/CSE/DOSE",
  "coverage": {
   "note": "the coverage field has not been read for this issuer",
   "state": "not_read"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 724,
     "median_cadence_gap_days": 19.5,
     "median_filings": 6,
     "median_latency_days": 17,
     "name": "CSE"
    },
    "sector": {
     "issuers": 200,
     "median_cadence_gap_days": 17.5,
     "median_filings": 7,
     "median_latency_days": 14,
     "name": "Life Sciences"
    }
   },
   "by_type": {
    "newswire_release": 9
   },
   "cadence_median_gap_days": 16.5,
   "filing_days": 7,
   "filings": 9,
   "latency_days": 7,
   "latest": [
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://www.newsfilecorp.com/release/321905/Rapid-Dose-Announces-Proposed-Debt-Settlement?lang=fr",
     "title": "Rapid Dose Announces Proposed Debt Settlement",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://www.newsfilecorp.com/release/321905/Rapid-Dose-Announces-Proposed-Debt-Settlement",
     "title": "Rapid Dose Announces Proposed Debt Settlement",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.newsfilecorp.com/release/320149/Rapid-Dose-Therapeutics-Ships-QuickStripTM-Production-Line-to-Callan-JMBs-Texas-cGMP-Facility?lang=fr",
     "title": "Rapid Dose Therapeutics Ships QuickStrip(TM) Production ...",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-10-21",
     "source": "https://www.newsfilecorp.com/release/320149/Rapid-Dose-Therapeutics-Ships-QuickStripTM-Production-Line-to-Callan-JMBs-Texas-cGMP-Facility",
     "title": "Rapid Dose Therapeutics Ships QuickStrip(TM) Production Line to Callan JMB's Texas cGMP Facility",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-07-07",
     "source": "http://www.newsfilecorp.com/release/304185/Rapid-Dose-Therapeutics-Extends-Strategic-Collaboration-with-Global-Nicotine-Leader-and-Initiating-Saudi-Arabia-Commercialization",
     "title": "Rapid Dose Therapeutics Extends Strategic Collaboration with ...",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-10-30",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/DOSE",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "CSE"
   },
   "isin": {
    "market": "CA",
    "reason": "no ISIN found on issuer pages",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "market": "CA",
    "reason": "not searched",
    "state": "not_on_record"
   },
   "lei": {
    "market": "CA",
    "reason": "no ISIN",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Rapid Dose Therapeutics Corp."
   },
   "sector": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Life Sciences"
   },
   "security_type": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "CA",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "thecse.com listed-companies API (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://thecse.com/api/webapi/listed-companies/",
    "state": "sourced",
    "value": "DOSE"
   },
   "website": {
    "market": "CA",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": [],
   "listing": [],
   "name_change": [],
   "segment_move": []
  },
  "market": "CA",
  "node": "ca-cm-kg",
  "numbers_hash": "sha256:a9e6022859743c3058a7dd9b512ba0adfb3541e0ab7ffede66f8c016220270ca",
  "open_research": {
   "rows": [],
   "state": "not_read"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Paragraph (o) of the definition",
    "Paragraph (q) of the definition"
   ],
   "outcomes": {
    "Paragraph (o) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "Paragraph (q) of the definition": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json",
    "door": "https://mcp.ca-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1",
   "section": "ca.aio.v11"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.ca-cm-kg.ai/record/CSE/DOSE",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a9e6022859743c3058a7dd9b512ba0adfb3541e0ab7ffede66f8c016220270ca",
 "path": "/ca/CSE/DOSE",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Rapid Dose Therapeutics Corp. is listed on the CSE under the ticker DOSE. The ISIN and LEI are not on the record, as no ISIN was found on issuer pages. Security type is Corporate, sector is Life Sciences, and segment is not on the record. Jurisdiction is not on the record, as it was not searched. Status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 9 filings in the twelve months to 2026-11-06, across 7 filing days, all of type newswire release. The median gap between filing days is 16.5 days. Days from the latest filing to the record date are 7. The latest filing is dated 2026-10-30 and is a newswire release. CSE peers, 724 issuers, show a median cadence gap of 19.5 days, a median of 6.0 filings, and a median latency of 17.0 days. Life Sciences peers, 200 issuers, show a median cadence gap of 17.5 days, a median of 7.0 filings, and a median latency of 14 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is SRCO Professional Corporation. Its location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, name change, domicile change or segment move events. Status is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "Under the Canadian know-your-product rule (NI 31-103), both client categories, paragraph (o) and paragraph (q) of the definition, return signal ACM-200, and both outcomes are determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The field has not been read. The number of research houses named on the issuer's investor-relations page is not on the record.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The field has not been read. The number of openly published research notes is not on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://thecse.com/api/webapi/listed-companies/"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.ca-cm-kg.ai/events/CSE/DOSE"
  },
  {
   "for": "the halt flag",
   "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100"
  },
  {
   "for": "the auditor",
   "source": "https://thecse.com/listings/rapid-dose-therapeutics-corp/"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.ca-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.ca-cm-kg.ai/record/CSE/DOSE"
  }
 ],
 "title": "Rapid Dose Therapeutics Corp. (DOSE) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}